Oncopeptides AB (publ) announced that the Board of Directors has appointed Dr. Monica Shaw as Chief Executive Officer, CEO, of Oncopeptides. She replaces Jakob Lindberg, who has been the CEO since November 15, 2021. Lindberg assumes his previous position as Chief Scientific Officer.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.44 SEK | +2.99% | +26.94% | -55.09% |
05-30 | Oncopeptides Issues Warrants Under Loan Deal with European Investment Bank | MT |
05-30 | Transcript : Oncopeptides AB, Q1 2024 Earnings Call, May 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-55.09% | 68.78M | |
+18.25% | 123B | |
+14.67% | 107B | |
-4.55% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-12.33% | 16.23B | |
+2.40% | 13.43B | |
+24.40% | 11.32B |
- Stock Market
- Equities
- ONCO Stock
- News Oncopeptides AB
- Oncopeptides AB Announces Jakob Lindberg Assumes Chief Scientific Officer